Review
doi: 10.1016/s1359-6446(03)02828-9.
ADME-Tox in drug discovery: integration of experimental and computational technologies
Affiliations
- PMID: 12963322
- DOI: 10.1016/s1359-6446(03)02828-9
Item in Clipboard
Review
ADME-Tox in drug discovery: integration of experimental and computational technologies
Drug Discov Today.
.
Abstract
Over the past ten years, in vitro experimental tools to characterize ADME-Tox profiles of compounds have been applied in early stages of the drug discovery process to increase the success rate of discovery programmes and to progress better candidates into drug development. Application of in silico ADME-Tox models has further enhanced discovery support, enabling virtual screening of compounds and thus, application of ADME-Tox at every stage of the discovery process. Ultimately, effective and efficient ADME-Tox support of discovery will depend on a complementary and synergistic use of experimental and in silico ADME-Tox.
Similar articles
-
In silico ADME/tox comes of age: twenty years later.Xenobiotica. 2024 Jul;54(7):352-358. doi: 10.1080/00498254.2023.2245049. Epub 2023 Aug 8. Xenobiotica. 2024. PMID: 37539466 Review.
-
Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.Handb Exp Pharmacol. 2019;260:327-367. doi: 10.1007/164_2019_239. Handb Exp Pharmacol. 2019. PMID: 31201557 Free PMC article.
-
In silico ADME-Tox modeling: progress and prospects.Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1147-1158. doi: 10.1080/17425255.2017.1389897. Epub 2017 Oct 13. Expert Opin Drug Metab Toxicol. 2017. PMID: 28988506 Review.
-
Systems-ADME/Tox: resources and network approaches.J Pharmacol Toxicol Methods. 2006 Jan-Feb;53(1):38-66. doi: 10.1016/j.vascn.2005.05.005. Epub 2005 Jul 27. J Pharmacol Toxicol Methods. 2006. PMID: 16054403 Review.
-
Early ADME/Tox studies and in silico screening.Drug Discov Today. 2002 Jan 1;7(1):25-7. doi: 10.1016/s1359-6446(01)02117-1. Drug Discov Today. 2002. PMID: 11790599 No abstract available.
Cited by
-
Synthesis, Anticancer Evaluation, Computer-Aided Docking Studies, and ADMET Prediction of 1,2,3-Triazolyl-Pyridine Hybrids as Human Aurora B Kinase Inhibitors.ACS Omega. 2021 Jan 5;6(2):1445-1455. doi: 10.1021/acsomega.0c05116. eCollection 2021 Jan 19. ACS Omega. 2021. PMID: 33490804 Free PMC article.
-
Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs.Sci Rep. 2023 Oct 16;13(1):17523. doi: 10.1038/s41598-023-43805-4. Sci Rep. 2023. PMID: 37845281 Free PMC article.
-
Digging into Lipid Membrane Permeation for Cardiac Ion Channel Blocker d-Sotalol with All-Atom Simulations.Front Pharmacol. 2018 Feb 1;9:26. doi: 10.3389/fphar.2018.00026. eCollection 2018. Front Pharmacol. 2018. PMID: 29449809 Free PMC article.
-
In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents.Molecules. 2023 Jan 5;28(2):555. doi: 10.3390/molecules28020555. Molecules. 2023. PMID: 36677621 Free PMC article.
-
Preclinical evaluation of strasseriolides A-D, potent antiplasmodial macrolides isolated from Strasseria geniculata CF-247,251.Malar J. 2021 Dec 5;20(1):457. doi: 10.1186/s12936-021-03993-8. Malar J. 2021. PMID: 34865639 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
